Publications

Preprints

*Scientific papers that have not been subjected to a formal peer review process.

2020-08

  • Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults
    Abstract DOI PDF
  • Sero-prevalence findings from metropoles in Pakistan: implications for assessing COVID-19 prevalence and case-fatality within a dense, urban working population
    Abstract DOI PDF
  • High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; a prospective cohort study in England
    Abstract DOI PDF
  • SARS-CoV-2 seroprevalence survey among 18,000 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region
    Abstract DOI PDF

2020-07

  • Covid-19 serology in nephrology health care workers
    Abstract DOI PDF
  • Seroprevalence of SARS-CoV-2 IgG Antibodies in Utsunomiya City, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household- and population-based study
    Abstract DOI PDF
  • SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study
    Abstract DOI PDF
  • SARS-CoV-2 serosurvey in Health Care Workers of the Veneto Region
    Abstract DOI PDF
  • High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results
    Abstract DOI PDF
  • Humoral Response Dynamics Following Infection with SARS-CoV-2
    Abstract DOI PDF
  • Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
    Abstract DOI PDF
  • Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates
    Abstract DOI PDF
  • Qualitative Changes in the SARS-CoV-2 Antibody Response in the Post-Infection Phase Impact the estimates of infections in Population-Based Seroprevalence Studies
    Abstract DOI PDF
  • Seroprevalence of Hospital Staff in Province with Zero COVID-19 cases
    Abstract DOI PDF
  • Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study
    Abstract DOI PDF
  • Community-level SARS-CoV-2 Seroprevalence Survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research.
    Abstract DOI PDF
  • Covid-19 infection and attributable mortality in UK Long Term Care Facilities: Cohort study using active surveillance and electronic records (March-June 2020)
    Abstract DOI PDF
  • Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020
    Abstract DOI PDF
  • Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers
    Abstract DOI PDF
  • Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
    Abstract DOI PDF
  • SARS-CoV-2 Seroprevalence Among Parturient Women
    Abstract DOI PDF
  • Joint Detection of Serum IgM/IgG Antibody is An Important Key to Clinical Diagnosis of SARS-COV-2 Infection
    Abstract DOI PDF
  • SARS-CoV-2 Seroprevalence Rates of Children in Louisiana During the State Stay at Home Order.
    Abstract DOI PDF
  • Initial characterisation of ELISA assays and the immune response of the clinically correlated SARS-CoV-2 biobank SERO-BL-COVID-19 collected during the pandemic onset in Switzerland
    Abstract DOI PDF
  • Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients
    Abstract DOI PDF

2020-06

  • Differential occupational risks to healthcare workers from SARS-CoV-2: A prospective observational study
    Abstract DOI PDF
  • SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission
    Abstract DOI PDF
  • A cross-sectional study of immune seroconversion to SARS-CoV-2 in front-line maternity health professionals
    Abstract DOI PDF
  • COVID-19 Antibody in Thai Community Hospitals
    Abstract DOI PDF
  • Seroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States, March 23-May 3, 2020
    Abstract DOI PDF
  • Seroprevalence of SARS-CoV-2 IgG Specific Antibodies among Healthcare Workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave
    Abstract DOI PDF
  • Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA).
    Abstract DOI PDF
  • A primary care approach to the COVID-19 pandemic: clinical features and natural history of 2,073 suspected cases in the Corona Sao Caetano programme, Sao Paulo, Brazil
    Abstract DOI PDF
  • Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19
    Abstract DOI PDF
  • First results from the UK COVID-19 Serology in Oncology Staff Study (CSOS)
    Abstract DOI PDF
  • SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers
    Abstract DOI PDF
  • SEROPREVALENCE AND CLINICAL SPECTRUM OF SARS-CoV-2 INFECTION IN THE FIRST VERSUS THIRD TRIMESTER OF PREGNANCY
    Abstract DOI PDF
  • Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China
    Abstract DOI PDF
  • SARS-CoV-2 Community Transmission During Shelter-in-Place in San Francisco
    Abstract DOI PDF
  • Seroprevalence of Antibodies to SARS-CoV-2 in Healthcare Workers in Non-epidemic Region: A Report from Iwate Prefecture in Japan
    Abstract DOI PDF
  • A population-based study of the prevalence of COVID-19 infection in Espirito Santo, Brazil: methodology and results of the first stage
    Abstract DOI PDF
  • Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan -implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
    Abstract DOI PDF
  • Seroprevalence against COVID-19 and follow-up of suspected cases in primary health care in Spain
    Abstract DOI PDF
  • Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a region heavily affected by COVID-19 pandemic
    Abstract DOI PDF
  • Serology-informed estimates of SARS-COV-2 infection fatality risk in Geneva, Switzerland
    Abstract DOI PDF
  • Antibody response to infectious diseases and other factors accurately predict COVID-19 infection and severity risk 10-14 years later: a retrospective UK Biobank cohort study
    Abstract DOI PDF
  • SARS-CoV-2 virus and antibodies in front-line Health Care Workers in an acute hospital in London: preliminary results from a longitudinal study
    Abstract DOI PDF
  • Serological Analysis of New York City COVID19 Convalescent Plasma Donors
    Abstract DOI PDF
  • Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium: a prospective cross-sectional study of residual samples
    Abstract DOI PDF
  • Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes
    Abstract DOI PDF
  • A how-to-guide to building a robust SARS-CoV-2 testing program at a university-based health system
    Abstract DOI PDF
  • Dynamics of the SARS-CoV-2 epidemic in the earliest-affected areas in Italy: 1 Mass screening for SARS-CoV-2 serological positivity (SARS-2-SCREEN).
    Abstract DOI PDF
  • Covid-19 Seroprevalence rate in healthy blood donors from a community under strict lockdown measures
    Abstract DOI PDF
  • Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing
    Abstract DOI PDF
  • Antibody profiling of COVID-19 patients in an urban low-incidence region in Northern Germany
    Abstract DOI PDF
  • High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay
    Abstract DOI PDF
  • Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City
    Abstract DOI PDF
  • Serological surveys in Reunion Island of the first hospitalized patients revealed that long-lived immunoglobulin G antibodies specific against SARS-CoV2 virus are rapidly vanishing in severe cases
    Abstract DOI PDF
  • The prevalence of antibodies to SARS-CoV-2 in asymptomatic healthcare workers with intensive exposure to COVID-19
    Abstract DOI PDF

2020-05

  • Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states
    Abstract DOI PDF
  • Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
    Abstract DOI PDF
  • SARS-CoV-2 SEROPREVALENCE AMONG ALL WORKERS IN A TEACHING HOSPITAL IN SPAIN: UNMASKING THE RISK.
    Abstract DOI PDF
  • Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak
    Abstract DOI PDF
  • IgG serology in health care and administrative staff populations from 7 hospital representative of different exposures to SARS-CoV-2 in Lombardy, Italy
    Abstract DOI PDF
  • Prioritizing COVID-19 tests based in Participatory Surveillance and Spatial Scanning.
    Abstract DOI PDF
  • SARS-CoV-2 IgG Antibody Responses in New York City
    Abstract DOI PDF
  • Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya
    Abstract DOI PDF
  • Study on the expression levels of antibodies against SARS-CoV-2 at different period of disease and its related factors in 192 cases of COVID-19 patients
    Abstract DOI PDF
  • Diligent medical activities of a publicly designated medical institution for infectious diseases pave the way for overcoming COVID-19: A positive message to people working at the cutting edge
    Abstract DOI PDF
  • Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area
    Abstract DOI PDF
  • SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area
    Abstract DOI PDF
  • Anti-SARS-CoV-2 IgG antibodies are associated with reduced viral load
    Abstract DOI PDF
  • Early antibody response to SARS-CoV-2
    Abstract DOI PDF
  • Early experiences with antibody testing in a Flemish nursing home during an acute COVID-19 outbreak: a retrospective cohort study.
    Abstract DOI PDF
  • Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
    Abstract DOI PDF
  • Susceptibility-adjusted herd immunity threshold model and potential R0 distribution fitting the observed Covid-19 data in Stockholm
    Abstract DOI PDF
  • Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients
    Abstract DOI PDF
  • Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience
    Abstract DOI PDF
  • Serological prevalence of antibodies to SARS CoV-2 amongst cancer centre staff
    Abstract DOI PDF
  • Experience of quantitative SARS-CoV-2 antibody screening of health-care workers in the southern part of Kyoto city during COVID-19 peri-pandemic period
    Abstract DOI PDF
  • SARS-CoV-2 seroconversion in health care workers
    Abstract DOI PDF
  • Perceived versus proven SARS-CoV-2 specific immune responses in health care workers
    Abstract DOI PDF
  • Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.
    Abstract DOI PDF
  • SARS-CoV-2 Antibody responses do not predict COVID-19 disease severity
    Abstract DOI PDF
  • SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak
    Abstract DOI PDF
  • SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Sibenik-Knin County, Croatia
    Abstract DOI PDF
  • COVID-19 SCREENING AND MONITORING OF ASYMPTOMATIC HEALTH WORKERS WITH A RAPID SEROLOGICAL TEST
    Abstract DOI PDF
  • Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event
    Abstract DOI PDF
  • Repeated population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil
    Abstract DOI PDF
  • Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland
    Abstract DOI PDF
  • Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo
    Abstract DOI PDF
  • A national prospective cohort study of SARS/COV2 pandemic outcomes in the U.S.: The CHASING COVID Cohort
    Abstract DOI PDF
  • Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
    Abstract DOI PDF
  • Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.
    Abstract DOI PDF
  • Seroprevalence of COVID-19 virus infection in Guilan province, Iran
    Abstract DOI PDF
  • Severe Acute Respiratory Syndrome Coronavirus 2 Serology in Asymptomatic Healthcare Professionals: Preliminary Experience of a Tertiary Italian Academic Center.
    Abstract DOI PDF

2020-04

  • Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors
    Abstract DOI PDF
  • Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19
    Abstract DOI PDF
  • Cluster of COVID-19 in northern France: A retrospective closed cohort study
    Abstract DOI PDF
  • COVID-19 Antibody Seroprevalence in Santa Clara County, California
    Abstract DOI PDF
  • RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING
    Abstract DOI PDF

2020-03

  • Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice
    Abstract DOI PDF

Published

*Scientific papers that have been peer-reviewed and published in a scientific journal.

2020-07

  • SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity
    Abstract DOI
  • SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study
    Abstract DOI

2020-05

  • Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland
    Abstract PDF